We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First Patient Dosed in Phase II Clinical Trial of NKTR-102 in Ovarian Cancer

News   Jan 14, 2009

 
First Patient Dosed in Phase II Clinical Trial of NKTR-102 in Ovarian Cancer
 
 
Advertisement
 

RELATED ARTICLES

Study Indicates a Lack of Diversity in COVID-19 Clinical Trials

News

Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials, according to a new study.

READ MORE

Russia’s COVID-19 Vaccine “Approved" Despite No Phase III Data

News

The scientific community has been left somewhat perplexed today after Russian President Vladamir Putin announced that Russian authorities have approved the world's first COVID-19 vaccine.

READ MORE

Molecular Switch Turns on Brown Fat Energy Burn

News

An international research team have discovered how to activate brown fat in humans, which may lead to new treatments for type 2 diabetes and obesity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE